Literature DB >> 35903622

Lophomonas and Mycobacterium co-infection: the first molecular evidence to overcome potential diagnostic pitfalls.

Amirmasoud Taheri1, Mahdi Fakhar1, Ali Sharifpour1, Maryam Nakhaei1, Elham Sadat Banimostafavi1.   

Abstract

Lophomoniasis is an emerging protozoan disease that mostly involves the lungs. Because the disease has similar symptoms to other pulmonary infections such as tuberculosis, most cases are underdiagnosed. Here, we present a patient with co-infection of Lophomonas/Mycobacterium.
© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Year:  2022        PMID： 35903622      PMCID： PMC9318889          DOI： 10.1093/omcr/omac064

Source DB:  PubMed          Journal:  Oxf Med Case Reports        ISSN： 2053-8855


  11 in total

1.  First Molecular Diagnosis of Lophomoniasis: the End of a Controversial Story.

Authors:  Mahdi Fakhar; Maryam Nakhaei; Ali Sharifpour; Hamed Kalani; Elham Sadat Banimostafavi; Siavash Abedi; Sepideh Safanavaei; Masoud Aliyali
Journal:  Acta Parasitol       Date:  2019-06-05       Impact factor: 1.440

Review 2.  Clinical Aspects of Adult Tuberculosis.

Authors:  Robert Loddenkemper; Marc Lipman; Alimuddin Zumla
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-06       Impact factor: 6.915

3.  Tuberculosis: a global health problem.

Authors:  K Zaman
Journal:  J Health Popul Nutr       Date:  2010-04       Impact factor: 2.000

Review 4.  Bronchopulmonary infection of Lophomonas blattarum: a case and literature review.

Authors:  Jian Xue; Ying-Li Li; Xue-Mei Yu; Dai-Kun Li; Ming-Fang Liu; Jing-Fu Qiu; Jian-Jiang Xue
Journal:  Korean J Parasitol       Date:  2014-10-22       Impact factor: 1.341

5.  Pulmonary Infection with Lophomonas blattarum.

Authors:  Qin Ding; Kunling Shen
Journal:  Indian J Pediatr       Date:  2020-06-26       Impact factor: 1.967

6.  Bacteriologically confirmed extra pulmonary tuberculosis and treatment outcome of patients consulted and treated under program conditions in the littoral region of Cameroon.

Authors:  Teyim Pride Mbuh; Irene Ane-Anyangwe; Wandji Adeline; Benjamin D Thumamo Pokam; Henry Dilonga Meriki; Wilfred Fon Mbacham
Journal:  BMC Pulm Med       Date:  2019-01-17       Impact factor: 3.317

7.  First Co-morbidity of Lophomonas blattarum and COVID-19 Infections: Confirmed Using Molecular Approach.

Authors:  Maryam Nakhaei; Mahdi Fakhar; Ali Sharifpour; Elham Sadat Banimostafavi; Zakaria Zakariaei; Hossein Mehravaran; Reza Saberi; Sepideh Safanavaei; Siavash Abedi; Masoud Aliyali; Mostafa Soleimani
Journal:  Acta Parasitol       Date:  2021-10-22       Impact factor: 1.534

8.  Cavitary pulmonary lesions following emerging lophomoniasis: A novel perspective.

Authors:  Amirmasoud Taheri; Mahdi Fakhar; Ali Sharifpour; Elham Sadat Banimostafavi
Journal:  Respirol Case Rep       Date:  2022-02-03

9.  Morphological and Molecular Identification of Emerged Lophomonas blattarum Infection in Mazandaran Province, Northern Iran: First Registry-Based Study.

Authors:  Mahdi Fakhar; Maryam Nakhaei; Ali Sharifpour; Sepideh Safanavaei; Sivash Abedi; Rabeeh Tabaripour; Masoud Aliyali; Mostafa Modanloo; Reza Saberi; Hamed Kalani; Elham Sadat Banimostafavi
Journal:  Acta Parasitol       Date:  2021-06-11       Impact factor: 1.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.